News

The company plans €7m investment in cyclotron for commercial production of FDG and also to construct GMP laboratories for research and development of new radiodiagnostic agents at the

Droxidopa is a synthetic catecholamine that is directly converted to norepinephrine (NE) via decarboxylation, resulting in increased levels of NE in the nervous system, both centrally and peripherally.

The FDA approved Gammagard Liquid is indicated as replacement therapy for primary humoral immunodeficiency in adult and pediatric patients two years of age or older. In 44 patients

The company developed Bronchitol to aid clear the airways of CF patients. Pharmaxis CEO Alan Robertson said that patients living with cystic fibrosis in Europe will now be

The company has also received similar patent from the Canadian Intellectual Property Office, covering the North American territories. Ampio CEO Michael Macaluso said Optina is an ultra-low oral

The US District Court has ruled in favor of Merck in two jointly related patent infringement suits. Merck general counsel and executive vice president Bruce Kuhlik said, "The

Arzerra (ofatumumab) is submitted for the approval to treat chronic lymphocytic leukemia (CLL). Genmab chief executive officer Jan van de Winkel said, "This marks another important achievement in

The products include low particulate carboys and bottles, manufactured from resins approved for medical applications, to store and transport biopharmaceuticals, culture media, bulk vaccines and other biotech materials.

Cholestor supplement can keep cholesterol ratios in balance naturally, claims the company. VitalMax Vitamins medical expert Mark Rosenberg said Cholestor helps put HDL and LDL into perfect ratio